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Genetic Testing, Physicians and the Law: Will the
Tortoise Ever Catch Up with the Hare?
Lee Black, J.D., LL.M., *
Jacques Simard,Ph.D., **
BarthaMariaKnoppers, Ph.D.
As science progresses and new treatments for
(and genetic susceptibility to) disease are discovered,
questions arise as to how physicians relate this
information to patients. This is especially important
in the field of cancer research, where the study of
genetics has changed how researchers think about
causes and therapies. The use of genetic testing to
identify specific mutations known to increase risk of
cancer now allows patients to know of their potential
risk and to be proactive with prevention decisions.
However, the rapid increase in the use of genetic testing creates difficulty
for physicians who must counsel patients on whether to take genetic tests
and must then explain what the results mean. Complicating this already
complex situation is the desire of patients to receive testing based upon
their own perceived risks rather than medically determined risks. As
genetic tests become cheaper and more widespread and as potential patients
continue to hear and read sensational stories about genetic disorders and
testing, the question becomes: Will physicians face new liabilities based
upon inaccurate or misleading results, or for disclosing (or failing to
disclose) relevant results to family members of a patient.
I. THE GENETIC HARE

There is no doubt that the field of medical genetics is changing rapidly.
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However, science can be slow to follow up on early promises. In the early
1990s, scientists, along with the media, trumpeted the mapping of the
human genome and its impact on medical science. It was expected that,
within decades, the genetic foundation of susceptibility for a plethora of
diseases would be discovered. While it is true that there have been many
important discoveries-including that of the BRCA 1 and BRCA 2
(standing for BReast CAncer) genes and their mutations (hereinafter BRCA
mutations)-two decades after the initiation of the Human Genome Project,
much of the early promise remains unfulfilled.
We are left with the general knowledge that our genes might be the cause
of, or at least a contributor to, many diseases, but we have no specific
knowledge of what these genes and mutations are. In the field of hereditary
breast and ovarian cancer (HBOC), some mutations, such as the BRCA
mutations, are known, but researchers believe that many others remain to be
discovered and that known mutations must be studied further to determine
their effect on cancer development. Regardless, genetics and 'personalized
medicine' (the use of an individual's genotype to guide treatment decisions)
are regarded as the future of health care. The question remains whether
physicians, their patients and the law are prepared for this future.
II. PHYSICIANS AND PATIENTS
The fields of genetics and genetic testing have exposed problems in how
physicians communicate with patients. To begin, although there are
guidelines and educational resources available for both, many physicians
are not adequately trained to understand the consequences of specific
genetic variations or to relay reliable information back to patients.1 Indeed,
it was recently noted that "only 11% of US and Canadian medical schools
reported practical training in the use of medical genetics as part of their
curricula.",2 As genetic testing becomes more commonplace, this lack of
training will likely result in a misleading interpretation of results that will
detrimentally affect both physicians and patients alike.
Secondly, although the general public's knowledge of the technical
aspects and risk of genomics and genetic testing are low, their attitude is
generally positive, which could lead to an increase in requests for testing
without sufficient comprehension of what tests actually entail. Although
obtaining a blood or cell sample is relatively low-risk, there are issues of

1. Keyan Salari, The Dawning Era of PersonalizedMedicine Exposes a Gap in Medical
Education, 6 PLoS MED. (2009), available at http://www.plosmedicine.org/article/
info%3Adoi%2F10.1371%2Fjournal.pmed.1000138; Joan L Bottorff et al., The Educational
Needs and Professional Roles of Canadian Physicians and Nurses Regarding Genetic
Testing andAdult Onset HereditaryDisease,8 CMTY. GENET. 80 (2005).
2. Id.
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privacy, consent, risk communication and possible psychosocial
consequences that accompany genetic results. A positive result could lead
to anxiety (whether the patient will develop the disease and when it could
happen, etc.), as well as the recommendation in some instances for
prophylactic surgery, such as a mastectomy or oophorectomy (removal of
the ovaries), to lessen the risk of breast or ovarian cancer. If the result is
either negative or non-conclusive, patients must be made to understand that
it does not necessarily mean that there is no potential genetic source for
cancer. An inappropriate interpretation of the risk assessment could lead to
unnecessary mental anguish or surgery or could cause a physician or patient
to fail to consider additional genetic risks. Legal action toward a physician
might follow.
Finally, a physician might believe it necessary to inform a patient's
relative of the result, if the patient refuses to inform a relative whose health
might be implicated. Siblings, parents, children, cousins and other family
members could be at risk of carrying the same mutation as the patient; for
example, children of a BRCA 1 or 2 mutation carrier have a fifty percent
chance of inheriting the same mutation. As genetic information is generally
relevant to more than one person, the question for physicians is whether
they have an obligation, or even the ability, to inform these third parties of
potential danger.3

III. RISK COMMUNICATION AND LIABILITY
One challenge for physicians in the environment of genetic medicine is
their ability to effectively communicate risk information to patients and
others. Post-test communication of risk raises a number of potential
liability issues for physicians. Recommending particular action, or inaction
in the case of negative results, could lead patients to take drastic steps, such
as prophylactic mastectomies for example, that would never be
recommended for non-carriers. Similarly, playing down potential and
unknown genetic risk in response to a negative test, especially for patients
with a strong family history of breast cancer, could cause inattentiveness to
other warning signs. Physicians could certainly be faced with liability in
these circumstances under current law.4
Another area with potential consequences for physicians is disclosure of
test results or genetic risk to family members of a patient who refuses to
inform family members of the results. There are precedents for breaching
3. Mireille Lacroix et al., Should Physicians Warn Patients'Relativesof Genetic Risks?,
178 CAN. MED. Assoc. J. 593 (2008).
4. Kathleen A. Mahoney, Malpractice Claims Resulting from Negligent Preconception
Genetic Testing: Do These Claims Present a Strain of Wrongful Birth or Wrongful
Conception, and Does the CategorizationEven Matter?, 39 SUFFOLK U. L. REv. 773 (2006).
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the otherwise sacrosanct confidentiality of medical information in both law
and ethics. Ethically, physicians can disclose patient information for the
protection of third parties in limited circumstances, or where required by
law, such as for public health. Legally, courts have accepted an obligation,
not just an option, to disclose confidential information when a third party is
in imminent danger (the Tarasoff rule).5 The question, however, is how
well these exceptions to confidentiality apply to genetic information. Two
American cases often cited regarding physician disclosure of genetic risk to
family members have contrary results, with one holding that telling patients
of the implication for their family is sufficient and the other requiring
disclosure directly to family members.6 Unfortunately, the law has not kept
up with scientific advances and the unique legal questions that are raised
within the field of genetics and genetic testing.
IV. THE SPEED OF TECHNOLOGY AND THE LEISURELY PACE OF LAW

Presently, there is little cohesive (or even coherent) legal guidance for
physicians faced with communicating the results of genetic tests. Many of
the current legal doctrines that ordinarily apply to medical issues miss
important aspects of genetics or are even entirely inapplicable. The
Tarasoffrule for breaching confidentiality, sometimes posited as a solution
for communicating genetic risk to patients' family members, is inadequate.7
Genetic risk is based on an inherent feature of a third party rather than a
danger controlled or caused by the patient. Furthermore, science has not yet
advanced far enough to quantify exact risks represented by genetic
variations associated with increased cancer susceptibility; rather, risks are
presented as a range of percentages. How can we determine the level of
danger posed and whether that is sufficient to permit or require breaching
confidentiality? Alternatively, the information gleaned from a genetic test
is considered by many to be familial, so why shouldn't a physician be
permitted to share it with others who might also have a need to know?
Statutory laws protecting medical information also fail to consider the
context of genetics. For instance, the privacy rules of the Health Insurance
Portability and Accountability Act (HIPAA) focus on the level of the
potential danger to the third party and the imminence of the threat. This
5. Tarasoffv. Regents of the University of California, 551 P.2d 334 (Cal. 1976). Canada
has adopted a similar rule, although it is more permissive than obligatory: the danger must

clear, serious and imminent. However, the danger can be to an identifiable group or a
specific individual. Smith v. Jones, [1999] S.C.R. 455.
6. Pate v. Threlkel, 661 So.2d 278 (Fla. 1995); Safer v. Estate of Pack, 677 A.2d 1188
(N.J. Super. Ct. App. Div. 1996).

7. The same is true in Canadian law. In the Province of Quebec, which is a civil law
regime, the Code of Ethics of Physicians sets forth similar requirements for when
confidentiality can be breached in instances of danger to third parties.
http://lawecommons.luc.edu/annals/vol19/iss1/24
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type of narrow focus is common in rules limiting disclosure but does not
take into account the nature of the information being protected-in the case
of genetic risk information, the fact that it applies to more than one person.
In addition, if the results of a test were shared with a third party such as an
insurer, would such a disclosure violate the rights of the parents of a patient,
at least one of whom would be implicated as being a carrier of the same
genetic mutation?
In addition, legal rules for liability based on failure to test, faulty results,
or other issues leading to injury may be difficult to apply when test-based
recommendations and interpretations change with new discoveries.
Medical science rapidly shifts and common practice can quickly change, as
illustrated by the recent modifications to mammography screening
recommendations issued by the US Preventive Services Task Force. 8 Will
physicians be faced with lawsuits for not following the previous
recommendations, or will patients who undergo surgical procedures based
on perceived risks seek liability when recommendations are later shown to
be incorrect or inaccurate? Current medical malpractice law does not
always address new science and is even more problematic when dealing
with unknown or limited risks-lawyers like absolutes, but genetics is
rarely decisive.
These issues have been discussed in the medical and legal spheres for
decades, and yet most remain unresolved. The slow legal response to these
important questions-and the failure of many physicians and most lawyers
to understand the intricacies of genetic medicine-has left a black hole in
the law.
V. IT IS TIME FOR SOME ACCELERATION

The current absence of guidance need not continue. There is much that
can and should be done in both medicine and law. The field of genetics is
changing how physicians ought to be incorporating genomics into their
practices. For one, genetic education for physicians and other health
professionals should become the standard, at least for those who might
regularly come into contact with genetic issues. Genetic education should
include both the science of genetics as well as the legal issues surrounding
genetic information. Medical student education has already made advances
in this direction, but older physicians should be offered additional
opportunities to gain this knowledge. This is an essential first step-it will
be much easier for physicians to communicate risk to patients and their
families if they fully understand the implications of genetic information.
Physician education is only a small part of the solution. As those who

8.

http://www.ahrq.gov/clinic/uspstf09/breastcanceribrcanrs.htm.
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create law and policy, attorneys, judges, and legislators must also become
better educated in the science of genetics and the consequences of related
laws and policies. Lawmakers have made some strides regarding genetic
information, such as the enactment of the Genetic Information
Nondiscrimination Act of 2008. However, the focus on potential genetic
discrimination by insurers and employers has come at the cost of other
important issues in genetics, and general comfort with the status quo is not
appropriate when it comes to genetics. As noted above, neither medical
malpractice law nor the law of confidentiality (privacy and disclosure laws)
are particularly well-suited to the arena of genetics. To continue with a
system that reacts without sufficient understanding is not tenable, especially
when scientific discoveries will continue exponentially regardless of the
law.
Better understanding of communication issues regarding genetic risk by
both physicians and the legal community will, in the end, help patients.
The physician who recognizes when a patient should have genetic testing
and a legal system that considers the information needs of patients and their
relatives, as well as the intricacies of genetic medicine, would much better
serve us than the present system. However, the current absence of legal
guidance in many areas of potential liability has created roadblocks to
effective education and communication, both between health professionals
and between health professionals and patients. Considering that genetics
has been and continues to be dubbed the future of medicine, it is vital that
the tortoise that is the law catch up with these expectations.
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